COCHW logo

Envoy Medical (COCHW) Financials

Balance sheets

Sep 30, 2024Jun 30, 2024Mar 31, 2024Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022

Total Assets

$9.4 M(+39.5%)$6.7 M(-20.6%)$8.5 M(-64.1%)$23.6 M(+810.2%)$2.6 M-$2.6 M

Current Assets

$7.1 M(+42.8%)$5.0 M(-35.4%)$7.7 M(-66.0%)$22.7 M(+1219.2%)$1.7 M-$1.6 M

Non Current Assets

$2.3 M(+29.9%)$1.7 M(+132.1%)$750.0 K(-14.0%)$872.0 K(+0.2%)$870.0 K-$908.0 K

Total Liabilities

$27.9 M(+46.0%)$19.1 M(+20.3%)$15.9 M(-8.4%)$17.3 M(-78.9%)$82.3 M-$38.8 M

Current Liabilities

$9.1 M(+12.6%)$8.1 M(+15.2%)$7.0 M(-48.6%)$13.6 M(+224.9%)$4.2 M-$2.5 M

Long Term Liabilities

$18.9 M(+70.4%)$11.1 M(+24.4%)$8.9 M(+137.9%)$3.7 M(-95.2%)$78.1 M-$36.2 M

Shareholders Equity

-$18.5 M(-49.6%)-$12.4 M(-67.1%)-$7.4 M(-218.4%)$6.3 M(+107.9%)-$79.7 M--$36.2 M

Book Value

-$18.5 M(-49.6%)-$12.4 M(-67.1%)-$7.4 M(-218.4%)$6.3 M(+107.9%)-$79.7 M--$36.2 M

Working Capital

-$1.9 M(+36.7%)-$3.1 M(-517.2%)$734.0 K(-92.0%)$9.1 M(+470.4%)-$2.5 M--$871.0 K

Cash And Cash Equivalents

$4.4 M(+153.4%)$1.7 M(-64.7%)$4.9 M(-33.5%)$7.4 M(+10841.2%)$68.0 K-$183.0 K

Accounts Payable

$1.8 M(+10.6%)$1.6 M(+74.0%)$913.0 K(-73.0%)$3.4 M(+43.3%)$2.4 M-$1.0 M

Accounts Receivable

$197.0 K(+13.2%)$174.0 K(-7.9%)$189.0 K(+73.4%)$109.0 K(+98.2%)$55.0 K-$41.0 K

Short Term Debt

----$676.0 K-$448.0 K

Long Term Debt

$15.4 M(+82.9%)$8.4 M(+61.8%)$5.2 M(+1081.6%)$440.0 K(-99.2%)$55.8 M-$34.0 M

Total Debt

$15.6 M(+81.8%)$8.6 M(+60.3%)$5.4 M(+809.3%)$589.0 K(-99.0%)$56.6 M-$34.5 M

Debt To Equity

-0.8(-21.7%)-0.7(+4.2%)-0.7(-900.0%)0.1(+112.7%)-0.7--0.9

Current Ratio

0.8(+27.4%)0.6(-43.6%)1.1(-34.1%)1.7(+307.3%)0.4-0.7

Quick Ratio

0.6(+45.2%)0.4(-53.3%)0.9(-42.7%)1.6(+1470.0%)0.1-0.1

Inventory

$1.6 M(+3.7%)$1.6 M(+8.7%)$1.5 M(+4.2%)$1.4 M(+7.0%)$1.3 M-$1.3 M

Retained Earnings

-$277.5 M(-2.7%)-$270.2 M(-2.0%)-$264.9 M(-5.5%)-$251.0 M(+0.6%)-$252.5 M--$226.0 M

PB Ratio

-------

Income statements

Sep 30, 2024Jun 30, 2024Mar 31, 2024Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022

EPS

-------

TTM EPS

-------

Revenue

$56.0 K(-17.6%)$68.0 K(+15.3%)$59.0 K(-26.3%)$80.0 K(+27.0%)$63.0 K(-19.2%)$78.0 K-

TTM Revenue

$183.0 K(-11.6%)$207.0 K(+2.5%)$202.0 K(-8.6%)$221.0 K(+56.7%)$141.0 K(+80.8%)$78.0 K-

Total Expenses

$5.0 M(+2.1%)$4.9 M(-0.6%)$5.0 M(+43.1%)$3.5 M(-23.7%)$4.5 M(+18.0%)$3.8 M-

Operating Expenses

$4.8 M(+3.4%)$4.7 M(-2.5%)$4.8 M(+46.6%)$3.3 M(-25.2%)$4.4 M(+19.2%)$3.7 M-

Cost Of Goods Sold

$187.0 K(-23.7%)$245.0 K(+60.1%)$153.0 K(-19.1%)$189.0 K(+16.7%)$162.0 K(-7.4%)$175.0 K-

TTM Cost Of Goods Sold

$585.0 K(-0.3%)$587.0 K(+16.5%)$504.0 K(-4.2%)$526.0 K(+56.1%)$337.0 K(+92.6%)$175.0 K-

Gross Profit

-$131.0 K(+26.0%)-$177.0 K(-88.3%)-$94.0 K(+13.8%)-$109.0 K(-10.1%)-$99.0 K(-2.1%)-$97.0 K-

TTM Gross Profit

-$402.0 K(-5.8%)-$380.0 K(-25.8%)-$302.0 K(+1.0%)-$305.0 K(-55.6%)-$196.0 K(-102.1%)-$97.0 K-

Gross Margin

-233.9%(+10.1%)-260.3%(-63.4%)-159.3%(-16.9%)-136.3%(+13.3%)-157.1%(-26.4%)-124.4%-

Operating Profit

-$5.0 M(-2.4%)-$4.9 M(+0.8%)-$4.9 M(-44.7%)-$3.4 M(+24.4%)-$4.5 M(-18.8%)-$3.8 M-

TTM Operating Profit

-$14.7 M(-12.1%)-$13.1 M(-3.0%)-$12.8 M(-9.7%)-$11.6 M(-41.0%)-$8.3 M(-118.8%)-$3.8 M-

Operating Margin

-8882.1%(-24.3%)-7147.1%(+13.9%)-8301.7%(-96.2%)-4231.3%(+40.5%)-7111.1%(-47.1%)-4834.6%-

Net Income

-$6.0 M(-51.0%)-$3.9 M(+37.0%)-$6.3 M(-501.1%)$1.6 M(+111.8%)-$13.2 M(+0.1%)-$13.3 M-

TTM Net Income

-$16.2 M(-86.9%)-$8.7 M(+51.8%)-$18.0 M(+28.0%)-$24.9 M(+5.9%)-$26.5 M(-100.0%)-$13.3 M-

Net Margin

-------

EBIT

-$5.7 M(-49.3%)-$3.8 M(+38.8%)-$6.2 M(-498.9%)$1.6 M(+111.8%)-$13.2 M(+0.1%)-$13.3 M-

TTM EBIT

-$15.7 M(-85.5%)-$8.5 M(+52.6%)-$17.9 M(+28.1%)-$24.9 M(+5.9%)-$26.5 M(-100.0%)-$13.3 M-

EBITDA

-$4.9 M(-1.9%)-$4.8 M(+0.9%)-$4.9 M(-405.5%)$1.6 M(+112.0%)-$13.2 M(+0.1%)-$13.2 M-

TTM EBITDA

-$14.6 M(-80.4%)-$8.1 M(+50.9%)-$16.5 M(+33.6%)-$24.9 M(+6.0%)-$26.4 M(-99.9%)-$13.2 M-

Selling, General & Administrative Expenses

$2.1 M(-0.3%)$2.1 M(-14.4%)$2.4 M(+71.4%)$1.4 M(-36.0%)$2.2 M(+27.5%)$1.7 M-

TTM SGA

$6.6 M(+11.1%)$6.0 M(-2.2%)$6.1 M(+12.9%)$5.4 M(+35.9%)$4.0 M(+127.5%)$1.7 M-

Depreciation And Amortization

$49.0 K(+16.7%)$42.0 K(+23.5%)$34.0 K(+17.2%)$29.0 K(0%)$29.0 K(+7.4%)$27.0 K-

TTM D&A

$125.0 K(+19.1%)$105.0 K(+14.1%)$92.0 K(+8.2%)$85.0 K(+51.8%)$56.0 K(+107.4%)$27.0 K-

Interest Expense

$264.0 K(+100.0%)$132.0 K(+266.7%)$36.0 K(+100.0%)$0.0(0%)$0.0(0%)$0.0-

TTM Interest Expense

$432.0 K(+157.1%)$168.0 K(+366.7%)$36.0 K(+100.0%)$0.0(0%)$0.0(0%)$0.0-

Income Tax

-------

TTM Income Tax

-------

PE Ratio

-------

PS Ratio

-------

Cashflow statements

Sep 30, 2024Jun 30, 2024Mar 31, 2024Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022

Cash From Operations

-$2.8 M(+42.8%)-$4.9 M(+16.1%)-$5.8 M(-631.9%)$1.1 M(+127.2%)-$4.0 M(-34.0%)-$3.0 M-

TTM CFO

-$13.6 M(-40.5%)-$9.7 M(-9.9%)-$8.8 M(-47.7%)-$5.9 M(+15.6%)-$7.0 M(-134.0%)-$3.0 M-

Cash From Investing

-$615.0 K(+22.1%)-$790.0 K(-624.8%)-$109.0 K(-75.8%)-$62.0 K(-463.6%)-$11.0 K(+81.4%)-$59.0 K-

TTM CFI

-$1.5 M(-57.5%)-$961.0 K(-428.0%)-$182.0 K(-37.9%)-$132.0 K(-88.6%)-$70.0 K(-18.6%)-$59.0 K-

Cash From Financing

$6.1 M(+144.0%)$2.5 M(-62.6%)$6.7 M(-57.5%)$15.7 M(+424.5%)$3.0 M(-25.0%)$4.0 M-

TTM CFF

$15.3 M(-38.7%)$24.9 M(-2.0%)$25.4 M(+11.8%)$22.7 M(+224.8%)$7.0 M(+75.0%)$4.0 M-

Free Cash Flow

-$3.4 M(+39.9%)-$5.7 M(+4.3%)-$6.0 M(-674.3%)$1.0 M(+125.6%)-$4.0 M(-31.8%)-$3.1 M-

TTM FCF

-$15.1 M(-42.0%)-$10.6 M(-18.4%)-$9.0 M(-47.5%)-$6.1 M(+14.6%)-$7.1 M(-131.8%)-$3.1 M-

CAPEX

$615.0 K(-22.1%)$790.0 K(+624.8%)$109.0 K(+75.8%)$62.0 K(+463.6%)$11.0 K(-81.4%)$59.0 K-

TTM CAPEX

$1.5 M(+57.5%)$961.0 K(+428.0%)$182.0 K(+37.9%)$132.0 K(+88.6%)$70.0 K(+18.6%)$59.0 K-

Dividends Paid

-------

TTM Dividends Paid

-------

TTM Dividend Per Share

-------

TTM Dividend Yield

-------

Payout Ratio

-------